first glp 1 approval Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Weight-loss GLP-1 pill approved for

Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing

Buffer and Reagent Preparation : Acts as a clean base for preparing solutions and buffers

If metabolic warning, blood and urine tests should be obtained, followed by delivery of 10% dextrose-containing intravenous fluid at a rate of 1.5 times maintenance (simultaneously with fluid boluses as necessary) ( If neurologic signs, perform magnetic resonance imaging (MRI) of the brain or computed tomography (CT) to rule out intracranial lesions, brain tumors or referral to a neurologist

8 weeks) significantly improves elevated blood urine nitrogen, serum creatinine, and urinary albumin excretion rate and alleviates renal hypertrophy, mesangial expansion and glomerular fibrosis in streptozocin-induced type 1 diabetic rat